PLoS ONE (Jan 2017)

Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5.

  • Joshi Stephen,
  • Tadafumi Yokoyama,
  • Nathanial J Tolman,
  • Kevin J O'Brien,
  • Elena-Raluca Nicoli,
  • Brian P Brooks,
  • Laryssa Huryn,
  • Steven A Titus,
  • David R Adams,
  • Dong Chen,
  • William A Gahl,
  • Bernadette R Gochuico,
  • May Christine V Malicdan

DOI
https://doi.org/10.1371/journal.pone.0173682
Journal volume & issue
Vol. 12, no. 3
p. e0173682

Abstract

Read online

Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts.